Eplerenone for phenotyping of CYP3A5 enzyme activity in saliva samples Grant US-11747352-B2 United States of America 05 Sep 2023
Amorphous and a crystalline form of genz 112638 hemitartrate as inhibitor of… Grant US-11458119-B2 United States of America 04 Oct 2022
Compositions for CYP450 phenotyping using saliva samples Grant US-10927398-B2 United States of America 23 Feb 2021
ELIGLUSTAT (GENZ 112638) AS INHIBITOR OF GLUCOSYLCERAMIDE SYNTHASE FOR USE IN A METHOD OF… Grant EP-3133070-B1 European Patent Office 14 Aug 2019
Perhexiline for use in the treatment of hypertrophic cardiomyopathy (HCM) Grant US-8697728-B2 United States of America 15 Apr 2014
Perhexiline for treating chronic heart failure Grant US-8697677-B2 United States of America 15 Apr 2014
Methods for selecting initial doses of psychotropic medications based on a CYP2D6 genotype Grant US-8688385-B2 United States of America 01 Apr 2014
Perhexiline for treating chronic heart failure Grant US-8470806-B2 United States of America 25 Jun 2013
Computational methods and systems for treatment in relation to modulation of CYP450… Grant US-8321151-B2 United States of America 27 Nov 2012
Computational methods and systems for suggesting modulators of CYP450 as treatment options Grant US-8315815-B2 United States of America 20 Nov 2012
Computational methods and systems for suggesting modulators of CYP450 as treatment options Grant US-8073633-B2 United States of America 06 Dec 2011
Computational methods and systems for treatment in relation to modulation of CYP450… Grant US-8073632-B2 United States of America 06 Dec 2011